Operating Lease, Right-of-Use Asset of KALA BIO, Inc. from 31 Dec 2017 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
KALA BIO, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2017 to 30 Jun 2025.
  • KALA BIO, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Jun 2025 was $1,507,000, a 19% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

KALA BIO, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $1,507,000 -$356,000 -19% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $1,601,000 -$344,000 -18% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $1,691,000 -$334,000 -16% 31 Dec 2024 10-Q 19 Nov 2025 2025 Q3
Q3 2024 $1,778,000 -$324,000 -15% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $1,863,000 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $1,945,000 +$1,939,000 +32317% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $2,025,000 +$2,009,000 +12556% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $2,102,000 +$2,068,000 +6082% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q1 2023 $6,000 -$1,379,000 -100% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $16,000 -$1,283,000 -99% 31 Dec 2022 10-K 29 Mar 2024 2023 FY
Q3 2022 $34,000 -$27,305,000 -100% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $51,000 -$27,902,000 -100% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $1,385,000 -$27,157,000 -95% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 $1,299,000 -$26,554,000 -95% 31 Dec 2021 10-K 03 Mar 2023 2022 FY
Q3 2021 $27,339,000 -$1,005,000 -3.5% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 $27,953,000 -$876,000 -3% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $28,542,000 -$766,000 -2.6% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 $27,853,000 -$1,928,000 -6.5% 31 Dec 2020 10-K 29 Mar 2022 2021 FY
Q3 2020 $28,344,000 -$1,904,000 -6.3% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $28,829,000 -$1,884,000 -6.1% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $29,308,000 -$1,835,000 -5.9% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $29,781,000 +$215,000 +0.73% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 $30,248,000 +$30,117,000 +22990% 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 $30,713,000 +$30,487,000 +13490% 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 $31,143,000 +$30,823,000 +9632% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 $29,566,000 +$29,153,000 +7059% 31 Dec 2018 10-K 12 Feb 2020 2019 FY
Q3 2018 $131,000 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 $226,000 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 $320,000 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 $413,000 31 Dec 2017 10-K 12 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.